Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review
Cancer Epidemiology · 2026-12 · 105 · 103244
DOI: 10.1016/j.canep.2026.103244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Epidemiology, 2026-12. Verfasst von Jin Mou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Binaytara, Bellevue, WA, United States. Electronic address: jin.m@binaytara.org. Die Arbeit nennt 51 Literaturangaben. Gefördert von: M J Murdock Charitable Trust.
Abstract (Originalsprache)
OBJECTIVE: Cervical cancer disproportionately affects low- and middle-income countries (LMICs), where over 90% of deaths occur and where cost, infrastructure, and low acceptability impede the WHO 2020-2025 goal of elimination by 2030. This review synthesizes advances in isothermal nucleic acid amplification-based HPV assays (AmpFire, ScreenFire, and Sentis), together with the signal-amplification comparator careHPV, and WHO policy for cervical cancer screening in LMICs, focusing on clinical performance, implementation logistics, and alignment with the 90-70-90 elimination targets. METHODS: A scoping review searched PubMed, Embase, Scopus, and WHO/IARC databases (January 2020 to October 2025) using MeSH terms and keywords related to isothermal amplification, HPV testing, and LMICs. Included studies evaluated assay performance, self-sampling, and program models in LMICs. Quality was assessed using the Newcastle-Ottawa Scale. RESULTS: Isothermal assays achieve 94.7-100% sensitivity for CIN3 + and 79-98% for CIN2 +, with self-sampling and dry-swab transport enhancing access. The shift to HPV DNA testing and screen-and-treat reduces loss-to-follow-up, but specificity that varies by clinical setting, from approximately 57% in colposcopy-referral cohorts to 89-92% in general screening populations, and cultural barriers persist. Telephonic linkage improves outcomes. CONCLUSION: Isothermal assays and WHO policies advance LMIC screening, but addressing specificity, acceptability, and cost-effectiveness is critical for the 90-70-90 targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Binaytara, Bellevue, WA, United States. Electronic address: jin.m@binaytara.org.
- Binaytara, Bellevue, WA, United States; Rajiv Gandhi University of Health Sciences, Bengaluru, India.
- Binaytara Cancer Trust and Binaytara Foundation Cancer Center (BTFCC), Janakpurdham, Nepal.
- Binaytara, Bellevue, WA, United States.
- Binaytara, Bellevue, WA, United States; University of Michigan - Ann Arbor, Ann Arbor, MI, United States.
- Binaytara, Bellevue, WA, United States; Issaquah High School, Issaquah, WA, United States.
Förderung
- M J Murdock Charitable Trust
Zitieren
APA
Mou, J., Shashikumar, S., Shah, A. K., Chaudhary, A., Chakraborty, P. L., Yang, A., & Shah, A. (2026). Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review. Cancer Epidemiology, 105, 103244. https://doi.org/10.1016/j.canep.2026.103244
Vancouver
Mou J, Shashikumar S, Shah AK, Chaudhary A, Chakraborty PL, Yang A, et al. Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review. Cancer Epidemiology. 2026;105:103244. doi:10.1016/j.canep.2026.103244
BibTeX
@article{Mou2026,
author = {Mou, Jin and Shashikumar, Suchit and Shah, Aman Kumar and Chaudhary, Amit and Chakraborty, Prity Lata and Yang, Angelina and Shah, Angira},
title = {Advances in isothermal nucleic acid amplification-based HPV assays for cervical cancer screening in low- and middle-income countries: A scoping review},
journal = {Cancer Epidemiology},
year = {2026},
volume = {105},
pages = {103244},
doi = {10.1016/j.canep.2026.103244}
}
EUVIMED